BBIO logo

BridgeBio Pharma, Inc. (BBIO) Cash From Investing

Annual CFI:

$60.78M+$6.75M(+12.49%)
December 31, 2024

Summary

  • As of today, BBIO annual cash from investing is $60.78 million, with the most recent change of +$6.75 million (+12.49%) on December 31, 2024.
  • During the last 3 years, BBIO annual cash from investing has risen by +$261.61 million (+130.27%).
  • BBIO annual cash from investing is now -86.59% below its all-time high of $453.15 million, reached on December 31, 2022.

Performance

BBIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Quarterly CFI:

$4.46M+$15.92M(+138.98%)
September 30, 2025

Summary

  • As of today, BBIO quarterly cash from investing is $4.46 million, with the most recent change of +$15.92 million (+138.98%) on September 30, 2025.
  • Over the past year, BBIO quarterly cash from investing has dropped by -$33.76 million (-88.32%).
  • BBIO quarterly cash from investing is now -97.02% below its all-time high of $149.70 million, reached on June 30, 2022.

Performance

BBIO Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

TTM CFI:

-$11.82M-$33.76M(-153.87%)
September 30, 2025

Summary

  • As of today, BBIO TTM cash from investing is -$11.82 million, with the most recent change of -$33.76 million (-153.87%) on September 30, 2025.
  • Over the past year, BBIO TTM cash from investing has dropped by -$75.77 million (-118.48%).
  • BBIO TTM cash from investing is now -102.59% below its all-time high of $456.98 million, reached on September 30, 2022.

Performance

BBIO TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BBIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+12.5%-88.3%-118.5%
3Y3 Years+130.3%-97.0%-102.6%
5Y5 Years+128.0%+110.1%+86.5%

BBIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-86.6%+130.3%-97.0%+139.0%-102.6%at low
5Y5-Year-86.6%+128.0%-97.0%+101.6%-102.6%+96.9%
All-TimeAll-Time-86.6%+128.0%-97.0%+101.6%-102.6%+96.9%

BBIO Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$4.46M(+139.0%)
-$11.82M(-153.9%)
Jun 2025
-
-$11.45M(-618.0%)
$21.94M(-39.8%)
Mar 2025
-
-$1.59M(+50.7%)
$36.43M(-40.1%)
Dec 2024
$60.78M(+12.5%)
-$3.24M(-108.5%)
$60.78M(-5.0%)
Sep 2024
-
$38.23M(+1157.8%)
$63.95M(+0.9%)
Jun 2024
-
$3.04M(-86.6%)
$63.41M(-1.7%)
Mar 2024
-
$22.75M(>+9900.0%)
$64.49M(+19.3%)
Dec 2023
$54.03M(-88.1%)
-$66.00K(-100.2%)
$54.03M(-25.0%)
Sep 2023
-
$37.68M(+814.8%)
$72.06M(-60.2%)
Jun 2023
-
$4.12M(-66.5%)
$181.24M(-44.5%)
Mar 2023
-
$12.30M(-31.5%)
$326.82M(-27.9%)
Dec 2022
$453.15M(+325.6%)
$17.96M(-87.8%)
$453.15M(-0.8%)
Sep 2022
-
$146.86M(-1.9%)
$456.98M(+22.8%)
Jun 2022
-
$149.70M(+8.0%)
$372.27M(+169.3%)
Mar 2022
-
$138.62M(+535.9%)
$138.26M(+149.0%)
Dec 2021
-$200.83M
$21.80M(-64.9%)
-$282.42M(-24.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
$62.15M(+173.7%)
-$226.20M(+31.9%)
Jun 2021
-
-$84.31M(+70.1%)
-$332.40M(+11.8%)
Mar 2021
-
-$282.05M(-461.5%)
-$377.07M(-1082.1%)
Dec 2020
-$52.99M(+75.6%)
$78.02M(+277.1%)
-$31.90M(+63.6%)
Sep 2020
-
-$44.05M(+65.8%)
-$87.74M(-95.6%)
Jun 2020
-
-$128.98M(-304.4%)
-$44.86M(-181.7%)
Mar 2020
-
$63.12M(+184.6%)
$54.91M(+616.7%)
Dec 2019
-$217.25M(-932.8%)
$22.18M(+1994.1%)
-$10.63M(+67.6%)
Sep 2019
-
-$1.17M(+96.0%)
-$32.81M(-1.8%)
Jun 2019
-
-$29.21M(-1103.6%)
-$32.23M(-177.6%)
Mar 2019
-
-$2.43M(-312.8%)
$41.55M(+1.4%)
Dec 2018
-$21.04M(-4433.6%)
-
-
Sep 2018
-
-$588.00K(-101.3%)
$40.99M(-1.4%)
Jun 2018
-
$44.57M(+1593.0%)
$41.58M(+1493.0%)
Mar 2018
-
-$2.98M
-$2.98M
Dec 2017
-$464.00K
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual cash from investing year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly cash from investing year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM cash from investing year-on-year change?

What is BridgeBio Pharma, Inc. annual cash from investing?

The current annual cash from investing of BBIO is $60.78M

What is the all-time high annual cash from investing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual cash from investing is $453.15M

What is BridgeBio Pharma, Inc. annual cash from investing year-on-year change?

Over the past year, BBIO annual cash from investing has changed by +$6.75M (+12.49%)

What is BridgeBio Pharma, Inc. quarterly cash from investing?

The current quarterly cash from investing of BBIO is $4.46M

What is the all-time high quarterly cash from investing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly cash from investing is $149.70M

What is BridgeBio Pharma, Inc. quarterly cash from investing year-on-year change?

Over the past year, BBIO quarterly cash from investing has changed by -$33.76M (-88.32%)

What is BridgeBio Pharma, Inc. TTM cash from investing?

The current TTM cash from investing of BBIO is -$11.82M

What is the all-time high TTM cash from investing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM cash from investing is $456.98M

What is BridgeBio Pharma, Inc. TTM cash from investing year-on-year change?

Over the past year, BBIO TTM cash from investing has changed by -$75.77M (-118.48%)
On this page